EPIC Program Annual Data Tables 2007-2008: Table IX
| Rank by Payment | Drug and Strength | Drug Type** | Number of Claims | EPIC Payments | Rank by Number of Claims |
|---|---|---|---|---|---|
| Top 20 Totals | 1,650,868 | $139,029,909 | |||
| Percent of Top 20 Drugs to Total EPIC Payments | 15.47% | 30.83% | |||
| 1 | PLAVIX (75 MG) | SS | 284,617 | $25,229,866 | 1 |
| 2 | NEXIUM (40 MG) | SS | 111,836 | $13,838,295 | 7 |
| 3 | PREVACID (30 MG) | SS | 72,720 | $9,284,156 | 21 |
| 4 | PROTONIX (40 MG) | BNMS | 93,415 | $8,968,359 | 11 |
| 5 | LIPITOR (20 MG) | SS | 97,839 | $8,453,821 | 10 |
| 6 | LIPITOR (10 MG) | SS | 126,355 | $7,866,583 | 4 |
| 7 | FOSAMAX (70 MG) | BNMS | 114,738 | $6,589,908 | 6 |
| 8 | ARICEPT (10 MG) | SS | 59,867 | $5,792,839 | 28 |
| 9 | PROCRIT (40000/ML) | BNMS | 3,511 | $5,203,889 | 596 |
| 10 | ACIPHEX (20 MG) | SS | 31,101 | $5,170,102 | 78 |
| 11 | SPIRIVA (18MCG) | SS | 78,469 | $5,152,439 | 17 |
| 12 | LIPITOR (40 MG) | SS | 55,969 | $4,922,181 | 33 |
| 13 | ADVAIR DISKUS (250-50MCG) | SS | 59,210 | $4,588,096 | 29 |
| 14 | ZETIA (10 MG) | SS | 69,259 | $4,578,531 | 24 |
| 15 | FLOMAX (0.4 MG) | SS | 75,380 | $4,216,119 | 19 |
| 16 | ACTONEL (35 MG) | SS | 75,103 | $4,208,832 | 20 |
| 17 | OMEPRAZOLE (20 MG) | Gen | 118,267 | $3,932,517 | 5 |
| 18 | CELEBREX (200 MG) | SS | 42,193 | $3,819,157 | 47 |
| 19 | PANTOPRAZOLE SODIUM (40 MG) | Gen | 49,065 | $3,718,592 | 41 |
| 20 | LIDODERM (5%(700MG)) | SS | 31,954 | $3,495,627 | 75 |
* Table IX lists the top 20 drugs ranked by EPIC Payments and number of adjudicated claims for the program year (October 1, 2007-September 30, 2008) as well as the percentage of the totals they represent for the year.
** Drug Type values are BNMS='Brand Name Multi-Source', Gen='Generic' and SS='Sole Source'.
